Biomeme, INC.
Company has developed a rapid pcr test for covid-19 and an array of chem-bio threats
Based in PA
AI Overview
With $410K in lobbying spend across 14 quarterly filings, Biomeme, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2022 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $140K |
| 2023 | $240K |
| 2024 | $30K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Biomeme, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Defense, MED, Health Issues
FY23 Defense Authorization and Appropriations Acts; FY23 Labor-HHS-Education Appropriations Acts
Advocacy to House and Senate to support Defense Authorization and Defense Appropriations efforts related funding from the Department of Defense to develop and deploy handheld devices to detect and ide
Advocacy to House and Senate to support Appropriations efforts related funding from the Department of Health and Human Services to develop and deploy handheld devices to detect and identify chemical,
Promoting policies and funding streams within the Defense Appropriations Subcommittee to bolster chemical and biological weapons detection capabilities
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.